# Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis

> **NCT05538026** · NA · COMPLETED · sponsor: **Bogomolets National Medical University** · enrollment: 53 (actual)

## Conditions studied

- Ulcerative Colitis Chronic Mild
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Mesalazine
- **BIOLOGICAL:** Fecal transplantation

## Key facts

- **NCT ID:** NCT05538026
- **Lead sponsor:** Bogomolets National Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-10
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05538026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05538026, "Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05538026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*